A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor

J Exp Med. 1989 May 1;169(5):1747-56. doi: 10.1084/jem.169.5.1747.

Abstract

We have prepared an mAb specific for a human cell surface component (termed anti-Fas mAb). Anti-Fas shows cell-killing activity that is indistinguishable from the cytolytic activity of TNF. Fas antigen was characterized by western blotting, indicating that Fas antigen is a cell surface protein with a molecular weight of 200,000, which is different from the molecular weight of TNF-R. Fas antigen, however, is co-downregulated with the TNF-R when cells sensitive to the cytolytic activity of TNF are incubated with either TNF or anti-Fas. In contrast, Fas antigen on cells insensitive to TNF is not co-downregulated with the TNF-R. We suggest that the cell-killing activity of TNF is mediated by Fas antigen associated with the TNF-R.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Monoclonal / immunology*
  • Antigens, Surface / analysis
  • Antigens, Surface / immunology*
  • Blotting, Western
  • Cell Survival
  • Colonic Neoplasms
  • Drug Synergism
  • Electrophoresis, Polyacrylamide Gel
  • Female
  • Humans
  • Immunoglobulin M
  • Interferon-gamma / pharmacology
  • Mice
  • Mice, Inbred BALB C
  • Molecular Weight
  • Receptors, Cell Surface / physiology*
  • Receptors, Tumor Necrosis Factor
  • Rhabdomyosarcoma
  • Tumor Cells, Cultured
  • Tumor Necrosis Factor-alpha / pharmacology
  • fas Receptor

Substances

  • Antibodies, Monoclonal
  • Antigens, Surface
  • Immunoglobulin M
  • Receptors, Cell Surface
  • Receptors, Tumor Necrosis Factor
  • Tumor Necrosis Factor-alpha
  • fas Receptor
  • Interferon-gamma